stockrowTrulieve Cannabis Corp.
TRLV Healthcare Drug Manufacturers Specialty & Generic
Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.
- Revenue
- −20.1%
- EPS
- −2,391.1%
- Free cash flow
- +24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow TRLV
Alert me
Trulieve Cannabis Corp. (TRLV) Book value per share
Trulieve Cannabis Corp.'s book value per share at the end of fiscal 2025 was 6.0×, down 9.13% from 6.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 4.0×. Over the past ten years it has ranged from 0.0× (fiscal 2020) to 15.4× (fiscal 2021); the current reading is higher than 33% of that period. Trulieve Cannabis Corp. ranks 29th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 6.0× | (9.13%) |
| FY2024 | 6.6× | (11.80%) |
| FY2023 | 7.5× | (27.31%) |
| FY2022 | 10.3× | (33.45%) |
| FY2021 | 15.4× | — |
| FY2020 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 4.0× | 0.62% |
| Jun 2026 | 4.0× | (33.42%) |
| Mar 2026 | 6.0× | (0.08%) |
| Dec 2025 | 6.0× | (3.67%) |
| 19 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| PBH Prestige Consumer Healthcare Inc. compare | 40.9× |
| ANIP ANI Pharmaceuticals, Inc. compare | 30.0× |
| PRGO Perrigo Company plc compare | 17.5× |
| TRLV Trulieve Cannabis Corp. | 4.0× |
| XERS Xeris Biopharma Holdings, Inc. compare | 0.3× |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.0× |
| RGC Regencell Bioscience Holdings Limited compare | 0.0× |
| ALVO Alvotech compare | 0.0× |
| BCRX BioCryst Pharmaceuticals, Inc. compare | −1.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on TRLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement